SOCW 6090 WK9 Assgn 1 Social Science homework help

SOCW 6090 WK9 Assgn 1 Social Science homework help

Click here to Order a Custom answer to this Question from our writers. It’s fast and plagiarism-free.

Discussion 1: Evidence-Based Interventions Used in Trauma

Individuals can experience trauma from public events at the national level or extremely private ones at the interpersonal level. In this Discussion, you analyze these two types of trauma, describing potential interventions and their effectiveness.

To prepare: Read the DSM-5 section on trauma and stressor-related disorders and review the Learning Resources on PTSD, disaster response, and trauma.

Then search the literature for studies related to an evidence-based intervention used to treat those suffering from trauma and stressor-related issues. Specifically, locate the following: (2 ARTICLES OF YOUR CHOICE) 

  • One study on treating symptoms resulting from a national traumatic event (e.g., natural disaster, mass shooting)
  • One study on treating symptoms resulting from an interpersonal trauma (e.g., rape, childhood sexual molestation, domestic violence)
By Day 3

Post a response in which you address the following:

  • Post the APA references for the two studies you located.
  • Provide a brief description of the traumatic events, including a summary of how they affected the individuals involved.
  • Describe the interventions discussed in the articles and explain how they addressed the psychosocial issues and needs of the individuals affected by the trauma.
  • Explain the effectiveness of the interventions, as stated in the articles.
  • Analyze and discuss the similarities and differences in the individuals’ needs depending on whether the issues occurred due to a national traumatic event or an interpersonal trauma.

Support your post with specific references to the resources. Be sure to provide full APA citations for your references.

DIAGNOSTIC AND STATISTICAL
MANUAL OF

MENTAL DISORDERS
F I F T H E D I T I O N

DSM-5TM

American Psychiatric Association

Officers 2012-2013
P residen t D ilip V. J este, M.D.

P resid en t-Elect J effrey A. Lieberm a n , M.D.
Tr ea su rer Da v id F a ssler, M.D.

Secreta ry R cxser Peele, M.D.

Assembly
Spea k er R. Sc o tt B en so n , M.D.

S peaker-Elect M elin da L. Yo u n g , M.D.

Board o f Trustees
Jeffrey A ka ka, M .D.

C aro l A. B ern stein, M.D.
B rL·̂ ̂C ro w ley, M.D.

An ita S. Everett, M.D.
J effrey G eller, M .D., M .P.H .

M ^ c D a v id G ra ff, M.D.
‘ J ^ e&A. G i^ eneVM.D.
Ju d ith F. Ka sh ta n , M.D.
M o lly K. M c Vo y, M .D.
J a m es E. N in in g er, M.D.
Jo h n M. O ldh a m , M .D.

A lan F. Sc h a tzberg , M.D.
A lik s . W id g e, M .D., P h .D.

E r ik R. V an d erlip, M .D .,
M em ber-in-T raining Tr u stee-E lect

DIAGNOSTIC AND STATISTICAL
MANUAL OF

MENTAL DISORDERS7
F I F T H E D I T I O N

DSM-5TM

New School Library

/«44

Amcriccin

O svch iatric

ADivi«ono(AmCT»MlVhijtiKAMod<tk>n

W ashin g ton , DC
Lon d on , E n gland

Copyright © 2013 American Psychiatric Association

DSM and DSM-5 are trademarks of the American Psychiatric Association. Use of these terms
is prohibited without permission of the American Psychiatric Association.

ALL RIGHTS RESERVED. Unless authorized in writing by the APA, no part of this book may
be reproduced or used in a manner inconsistent with the APA’s copyright. This prohibition
apphes to unauthorized uses or reproductions in any form, including electronic applications.

Correspondence regarding copyright permissions should be directed to DSM Permissions,
American Psychiatric Publishing, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209­
3901.

Manufactured in the United States of America on acid-free paper.

ISBN 978-0-89042-554-1 (Hardcover)

ISBN 978-0-89042-555-8 (Paperback)

American Psychiatric Association
1000 Wilson Boulevard
Arlington, VA 22209-3901
www.psych.org

The correct citation for this book is American Psychiatric Association: Diagnostic and Statisti­
cal Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Associa­
tion, 2013.

Library of Congress Cataloging-in-Publication Data
Diagnostic and statistical manual of mental disorders : DSM-5. — 5th ed.

p. ; cm.
DSM-5
DSM-V
Includes index.
ISBN 978-0-89042-554-1 (hardcover : alk. paper) — ISBN 978-0-89042-555-8 (pbk. : alk. paper)
I. American Psychiatric Association. II. American Psychiatric Association. DSM-5 Task Force,
m. Title: DSM-5. IV. Title: DSM-V.
[DNLM: 1. Diagnostic and statistical manual of mental disorders. 5th ed. 2. Mental Disorders—
classification. 3. Mental Disorders—diagnosis. WM 15]
RC455.2.C4
616.89Ό75—dc23

2013011061
British Library Cataloguing in Publication Data ^ n
A CIP record is available from the British Library. ^

Text Design—Tammy J. Cordova

Manufacturing—Edwards Brothers Malloy ^

cH

Contents

DSM-5 Classification…………………………………………………………xiii
Preface…………………………………………………………………………….. xli

Section I
DSM-5 Basics

Introduction……………………………………………………………………….. 5

Use of the M anual………………………………………………………………19

Cautionary Statement for Forensic Use of DSM-5………………… 25

Section II
Diagnostic Criteria and Codes

Neurodevelopmental Disorders………………………………………….. 31
Schizophrenia Spectrum and Other Psychotic Disorders……….87
Bipolar and Related Disorders………………………………………….. 123
Depressive Disorders………………………………………………………. 155
Anxiety Disorders………………………………………………………………189
Obsessive-Compulsive and Related Disorders………………….. 235
Trauma- and Stressor-Related Disorders…………………………… 265
Dissociative Disorders…………………………………………………….. 291
Somatic Symptom and Related Disorders…………………………. 309
Feeding and Eating Disorders………………………………………….. 329
Elimination Disorders………………………………………………………. 355
Sleep-Wake Disorders………………………………………………………. 361
Sexual Dysfunctions…………………………………………………………423
Gender Dysphoria…………………………………………………………….451

Disruptive, Impulse-Control, and Conduct Disorders…………..461
Substance-Related and Addictive Disorders……………………… 481
Neurocognitive Disorders…………………………………………………. 591
Personality Disorders………………………………………………………. 645
Paraphilic Disorders………………………………………………………… 685
Other Mental Disorders…………………………………………………… 707

Medication-Induced Movement Disorders
and Other Adverse Effects of M edication……………………….. 709

Other Conditions That May Be a Focus of Clinical Attention .. 715

Section III
Emerging Measures and Models

Assessment Measures…………………………………………………….. 733

Cultural Formulation………………………………………………………… 749

Alternative DSM-5 Model for Personality Disorders…………….761

Conditions for Further Study……………………………………………. 783

Appendix
Highlights of Changes From DSM-IV to DSM -5………………….. 809
Glossary of Technical Term s……………………………………………. 817
Glossary of Cultural Concepts of Distress…………………………. 833
Alphabetical Listing of DSM-5 Diagnoses and Codes

(ICD-9-CM and ICD-10-CM)……………………………………………. 839
Numerical Listing of DSM-5 Diagnoses and Codes

(ICD-9-CM)………………………………………………………………….. 863
Numerical Listing of DSM-5 Diagnoses and Codes

(ICD-10-CM)………………………………………………………………….877
DSM-5 Advisors and Other Contributors…………………………… 897

Index………………………………………………………………………………. 917

DSM-5 Task Force
D a vid J. K u pfer, M.D.

Task Force Chair
D a rrel A. R egier, M .D., M .P.H .

Task Force Vice-Chair
William E. Narrow, M.D.,

Research Director

Dan G. Blazer, M.D., Ph.D., M.P.H.
Jack D. Burke Jr., M.D., M.P.H.
William T. Carpenter Jr., M.D.
F. Xavier Castellanos, M.D.
Wilson M. Compton, M.D., M.P.E.
Joel E. Dimsdale, M.D.
Javier I. Escobar, M.D., M.Sc.
Jan A. Fawcett, M.D.
Bridget F. Grant, Ph.D., Ph.D. (2009-)
Steven E. Hyman, M.D. (2007-2012)
Dilip V. Jeste, M.D. (2007-2011)
Helena C. Kraemer, Ph.D.
Daniel T. Mamah, M.D., M.P.E.
James P. McNulty, A.B., Sc.B.
Howard B. Moss, M.D. (2007-2009)

Susan K. Schultz, M.D., Text Editor
Emily A. Kuhl, Ph.D., APA Text Editor

Charles P. O’Brien, M.D., Ph.D.
Roger Peele, M.D.
Katharine A. Phillips, M.D.
Daniel S. Pine, M.D.
Charles F. Reynolds III, M.D.
Maritza Rubio-Stipec, Sc.D.
David Shaffer, M.D.
Andrew E. Skodol II, M.D.
Susan E. Swedo, M.D.
B. Timothy Walsh, M.D.
Philip Wang, M.D., Dr.P.H. (2007-2012)
William M. Womack, M.D.
Kimberly A. Yonkers, M.D.
Kenneth J. Zucker, Ph.D.
Norman Sartorius, M.D., Ph.D., Consultant

APA Division of Research Staff on DSIVI-5
Darrel A. Regier, M.D., M.P.H.,

Director, Division o f Research
William E. Narrow, M.D., M.P.H.,

Associate Director
Emily A. Kuhl, Ph.D., Senior Science

Writer; Staff Text Editor
Diana E. Clarke, Ph.D., M.Sc., Research

Statistician

Lisa H. Greiner, M.S.S.A., DSM-5 Field
Trials Project Manager

Eve K. Moscicki, Sc.D., M.P.H.,
Director, Practice Research Network

S. Janet Kuramoto, Ph.D. M.H.S.,
Senior Scientific Research Associate,
Practice Research Network

Amy Porfiri, M.B.A.
Director o f Finance and Administration

Jennifer J. Shupinka, Assistant Director,
DSM Operations

Seung-Hee Hong, DSM Senior Research
Associate

Anne R. Hiller, DSM Research Associate
Alison S. Beale, DSM Research Associate
Spencer R. Case, DSM Research Associate

Joyce C. West, Ph.D., M.P.P.,
Health Policy Research Director, Practice
Research Network

Farifteh F. Duffy, Ph.D.,
Quality Care Research Director, Practice
Research Network

Lisa M. Countis, Field Operations
Manager, Practice Research Network

Christopher M. Reynolds,
Executive Assistant

APA Office of the IVIedlcal Director
Jam es H. S c u l l y Jr ., M.D.

Medical Director and CEO

Editorial and Coding Consultants
Michael B. First, M.D. Maria N. Ward, M.Ed., RHIT, CCS-P

DSM-5 Work Groups
ADHD and Disruptive Behavior Disorders

D a v id Sha ffer, M.D.
Chair

F. Xa v ier C a stella n o s, M.D.
Co-Chair

Paul J. Frick, Ph.D., Text Coordinator Luis Augusto Rohde, M.D., Sc.D.
Glorisa Canino, Ph.D. Rosemary Tannock, Ph.D.
Terrie E. Moffitt, Ph.D. Eric A. Taylor, M.B.
Joel T. Nigg, Ph.D. Richard Todd, Ph.D., M.D. (d. 2008)

Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic,
and Dissociative Disorders

K a th a rin e A. Ph illips, M.D.
Chair

Michelle G. Craske, Ph.D., Text Scott L. Rauch, M.D.
Coordinator H. Blair Simpson, M.D., Ph.D.

J. Gavin Andrews, M.D. David Spiegel, M.D.
Susan M. Bögels, Ph.D. Dan J. Stein, M.D., Ph.D.
Matthew J. Friedman, M.D., Ph.D. Murray B. Stein, M.D.
Eric Hollander, M.D. (2007-2009) Robert J. Ursano, M.D.
Roberto Lewis-Fernandez, M.D., M.T.S. Hans-Ulrich Wittchen, Ph.D.
Robert S. Pynoos, M.D., M.P.H.

Childhood and Adolescent Disorders
D an iel S. Pin e, M.D.

Chair
Ronald E. Dahl, M.D. James F. Leckman, M.D.
E. Jane Costello, Ph.D. (2007-2009) Ellen Leibenluft, M.D.
Regina Smith James, M.D. Judith H. L. Rapoport, M.D.
Rachel G. Klein, Ph.D. Charles H. Zeanah, M.D.

Eating Disorders
B. T im o th y W alsh, M.D.

Chair
Stephen A. Wonderlich, Ph.D., Richard E. Kreipe, M.D.

Text Coordinator Marsha D. Marcus, Ph.D.
Evelyn Attia, M.D. James E. Mitchell, M.D.
Anne E. Becker, M.D., Ph.D., Sc.M. Ruth H. Striegel-Moore, Ph.D.
Rachel Bryant-Waugh, M.D. G. Terence Wilson, Ph.D.
Hans W. Hoek, M.D., Ph.D. Barbara E. Wolfe, Ph.D. A.P.R.N.

Mood Disorders
J a n a . F a w c e t t , M.D.

Chair
Ellen Frank, Ph.D., Text Coordinator
Jules Angst, M.D. (2007-2008)
William H. Coryell, M.D.
Lori L. Davis, M.D.
Raymond J. DePaulo, M.D.
Sir David Goldberg, M.D.
James S. Jackson, Ph.D.

Kenneth S. Kendler, M.D., Ph.D.
(2007-2010)

Mario Maj, M.D., Ph.D.
Husseini K. Manji, M.D. (2007-2008)
Michael R. Phillips, M.D.
Trisha Suppes, M.D., Ph.D.
Carlos A. Zarate, M.D.

Neurocognitive Disorders
D ilip V. Je s te , M .D. (2007-2011)

Chair Emeritus
D an G. Bla zer, M .D., P h .D., M.P.H.

Chair
R o n a l d C. P e te r s e n , M .D., Ph.D.

Co-Chair
Mary Ganguli, M.D., M.P.H.,

Text Coordinator
Deborah Blacker, M.D., Sc.D.
Warachal Faison, M.D. (2007-2008)

Igor Grant, M.D.
Eric J. Lenze, M.D.
Jane S. Paulsen, Ph.D.
Perminder S. Sachdev, M.D., Ph.D.

Neurodevelopmental Disorders
Su sa n E. Sw ed o , M.D.

Chair
Gillian Baird, M.A., M.B., B.Chir.,

Text Coordinator
Edwin H. Cook Jr., M.D.
Francesca G. Happé, Ph.D.
James C. Harris, M.D.
Walter E. Kaufmann, M.D.
Bryan H. King, M.D.

Catherine E. Lord, Ph.D.
Joseph Piven, M.D.
Sally J. Rogers, Ph.D.
Sarah J. Spence, M.D., Ph.D.
Fred Volkmar, M.D. (2007-2009)
Amy M. Wetherby, Ph.D.
Harry H. Wright, M.D.

Personality and Personality Disorders^
A n d rew E. Sk o d o l, M.D.

Chair
Joh n M. O l d h a m , M.D.

Co-Chair
Robert F. Krueger, Ph.D., Text

Coordinator
Renato D. Alarcon, M.D., M.P.H.
Carl C. Bell, M.D.
Donna S. Bender, Ph.D.

Lee Anna Clark, Ph.D.
W. John Livesley, M.D., Ph.D. (2007-2012)
Leslie C. Morey, Ph.D.
Larry J. Siever, M.D.
Roel Verheul, Ph.D. (2008-2012)

̂The members of the Personality and Personality Disorders Work Group are responsible for the
alternative DSM-5 model for personality disorders that is included in Section III. The Section II
personality disorders criteria and text (with updating of the text) are retained from DSM-IV-TR.

Psychotic Disorders
W illiam T. C arpen ter J r ., M.D.

Chair
Deanna M. Barch, Ph.D., Text Dolores Malaspina, M.D., M.S.P.H.

Coordinator Michael J. Owen, M.D., Ph.D.
Juan R. Bustillo, M.D. Susan K. Schultz, M.D.
Wolfgang Gaebel, M.D. Rajiv Tandon, M.D.
Raquel E. Gur, M.D., Ph.D. Ming T. Tsuang, M.D., Ph.D.
Stephan H. Heckers, M.D. Jim van Os, M.D.

Sexual and Gender Identity Disorders
K en n eth J. Zu c k er, Ph .D.

Chair
Lori Brotto, Ph.D., Text Coordinator Martin P. Kafka, M.D.
Irving M. Binik, Ph.D. Richard B. Krueger, M.D.
Ray M. Blanchard, Ph.D. Niklas Langström, M.D., Ph.D.
Peggy T. Cohen-Kettenis, Ph.D. Heino F.L. Meyer-Bahlburg, Dr. rer. nat.
Jack Drescher, M.D. Friedemann Pfäfflin, M.D.
Cynthia A. Graham, Ph.D. Robert Taylor Segraves, M.D., Ph.D.

Sleep-Wake Disorders
C h a rles F. Reyn o ld s III, M.D.

Chair
Ruth M. O’Hara, Ph.D., Text Coordinator Kathy P. Parker, Ph.D., R.N.
Charles M. Morin, Ph.D. Susan Redline, M.D., M.P.H.
Allan I. Pack, Ph.D. Dieter Riemann, Ph.D.

Somatic Symptom Disorders
J o el E. D im sd a le, M.D.

Chair
James L. Levenson, M.D., Text Michael R. Irwin, M.D.

Coordinator Francis J. Keefe, Ph.D. (2007-2011)
Arthur J. Barsky III, M.D. Sing Lee, M.D.
Francis Creed, M.D. Michael Sharpe, M.D.
Nancy Frasure-Smith, Ph.D. (2007-2011) Lawson R. Wulsin, M.D.

Substance-Related Disorders
C h a rles P. O ‘B rien, M .D., Ph .D.

Chair
Th o m a s J. C ro w ley, M.D.

Co-Chair
Wilson M. Compton, M.D., M.P.E., Thomas R. Kosten, M.D. (2007-2008)

Text Coordinator Walter Ling, M.D.
Marc Auriacombe, M.D. Spero M. Manson, Ph.D. (2007-2008)
Guilherme L. G. Borges, M.D., Dr .Sc. A. Thomas McLellan, Ph.D. (2007-2008)
Kathleen K. Bucholz, Ph.D. Nancy M. Petry, Ph.D.
Alan J. Budney, Ph.D. Marc A. Schuckit, M.D.
Bridget F. Grant, Ph.D., Ph.D. Wim van den Brink, M.D., Ph.D.
Deborah S. Hasin, Ph.D. (2007-2008)

DSM-5 Study Groups
Diagnostic Spectra and DSM/ICD Harmonization

Steven E. H ym a n , M.D.
Chair (2007-2012)

William T. Carpenter Jr., M.D. William E. Narrow, M.D., M.P.H.
Wilson M. Compton, M.D., M.P.E. Charles P. O’Brien, M.D., Ph.D.
Jan A. Fawcett, M.D. John M. Oldham, M.D.
Helena C. Kraemer, Ph.D. Katharine A. Phillips, M.D.
David J. Kupfer, M.D. Darrel A. Regier, M.D., M.P.H.

Lifespan Developmental Approaches
E ric J. L en ze, M.D.

Chair
Susa n K. Sc h u ltz, M.D.

Chair Emeritus
Dan iel S. P in e, M.D.

Chair Emeritus
Dan G. Blazer, M.D., Ph.D., M.P.H.
F. Xavier Castellanos, M.D.
Wilson M. Compton, M.D., M.P.E.

Daniel T. Mamah, M.D., M.P.E.
Andrew E. Skodol II, M.D.
Susan E. Swedo, M.D.

Gender and Cross-Cultural Issues
K im berly A. Yo n kers, M.D.

Chair
R oberto L ew is-Fern â n d ez, M .D., M .T.S.

Co-Chair, Cross-Cultural Issues
Renato D. Alarcon, M.D., M.P.H.
Diana E. Clarke, Ph.D., M.Sc.
Javier I. Escobar, M.D., M.Sc.
Ellen Frank, Ph.D.
James S. Jackson, Ph.D.
Spiro M. Manson, Ph.D. (2007-2008)
James P. McNulty, A.B., Sc.B.

Leslie C. Morey, Ph.D.
William E. Narrow, M.D., M.P.H.
Roger Peele, M.D.
Philip Wang, M.D., Dr.P.H. (2007-2012)
William M. Womack, M.D.
Kermeth J. Zucker, Ph.D.

Psychiatric/General Medical Interface
L a w so n R. W u lsin, M.D.

Chair
Ronald E. Dahl, M.D.
Joel E. Dimsdale, M.D.
Javier I. Escobar, M.D., M.Sc.
Dilip V. Jeste, M.D. (2007-2011)
Walter E. Kaufmann, M.D.

Richard E. Kreipe, M.D.
Ronald C. Petersen, Ph.D., M.D.
Charles F. Reynolds III, M.D.
Robert Taylor Segraves, M.D., Ph.D.
B. Timothy Walsh, M.D.

Impairment and Disability
J a n e S. P a u ls e n , Ph.D .

Chair
J. Gavin Andrews, M.D.
Glorisa Canino, Ph.D.
Lee Anna Clark, Ph.D.
Diana E. Clarke, Ph.D., M.Sc.
Michelle G. Craske, Ph.D.

Hans W. Hoek, M.D., Ph.D.
Helena C. Kraemer, Ph.D.
William E. Narrow, M.D., M.P.H.
David Shaffer, M.D.

Diagnostic Assessment Instruments
J a ck D. Burk e Jr ., M .D., M .P.H.

Chair
Lee Anna Clark, Ph.D.
Diana E. Clarke, Ph.D., M.Sc.
Bridget F. Grant, Ph.D., Ph.D.

Helena C. Kraemer, Ph.D.
William E. Narrow, M.D., M.P.H.
David Shaffer, M.D.

DSM-5 Research Group
W illiam E. N a rro w , M .D., M.P.H.

Chair
Jack D. Burke Jr., M.D., M.P.H.
Diana E. Clarke, Ph.D., M.Sc.
Helena C. Kraemer, Ph.D.

David J. Kupfer, M.D.
Darrel A. Regier, M.D., M.P.H.
David Shaffer, M.D.

Course Specifiers and Glossary
W o lfg a n g G a ebel, M.D.

Chair
Ellen Frank, Ph.D.
Charles P. O’Brien, M.D., Ph.D.
Norman Sartorius, M.D., Ph.D.,

Consultant
Susan K. Schultz, M.D.

Dan J. Stein, M.D., Ph.D.
Eric A. Taylor, M.B.
David J. Kupfer, M.D.
Darrel A. Regier, M.D., M.P.H.

Before each disorder name, ICD-9-CM codes are provided, followed by ICD-IO-CM codes
in parentheses. Blank lines indicate that either the ICD-9-CM or the ICD-IO-CM code is not
applicable. For some disorders, the code can be indicated only according to the subtype or
specifier.

ICD-9-CM codes are to be used for coding purposes in the United States through Sep­
tember 30,2014. ICD-IO-CM codes are to be used starting October 1,2014.

Following chapter titles and disorder names, page numbers for the corresponding text
or criteria are included in parentheses.

Note for all mental disorders due to another medical condition: Indicate the name of
the other medical condition in the name of the mental disorder due to [the medical condi­
tion]. The code and name for the other medical condition should be listed first immedi­
ately before the mental disorder due to the medical condition.

Neurodevelopm ental Disorders (31)

Intellectual Disabilities (33)
319 (___.__) Intellectual Disability (Intellectual Developmental Disorder) (33)

Specify current severity;
(F70) Mild
(F71) Moderate
(F72) Severe
(F73) Profound

315.8 (F88) Global Developmental Delay (41)

319 (F79) Unspecified Intellectual Disability (Intellectual Developmental
Disorder) (41)

Communication Disorders (41)
315.39 (F80.9) Language Disorder (42)

315.39 (F80.0) Speech Sound Disorder (44)

315.35 (F80.81) Childhood-Onset Fluency Disorder (Stuttering) (45)
Note: Later-onset cases are diagnosed as 307.0 (F98.5) adult-onset fluency

disorder.
315.39 (F80.89) Social (Pragmatic) Communication Disorder (47)

307.9 (F80.9) Unspecified Communication Disorder (49)

Autism Spectrum Disorder (50)
299.00 (F84.0) Autism Spectrum Disorder (50)

Specify if: Associated with a known medical or genetic condition or envi­
ronmental factor; Associated with another neurodevelopmental, men­
tal, or behavioral disorder

Specify current severity for Criterion A and Criterion B: Requiring very
substantial support. Requiring substantial support. Requiring support

Specify if: With or without accompanying intellectual impairment. With
or without accompanying language impairment. With catatonia (use
additional code 293.89 [F06.1])

Attention-Deficit/Hyperactivity Disorder (59)
___.__ (__ .__) Attention-Deficit/Hyperactivity Disorder (59)

Specify whether:
314.01 (F90.2) Combined presentation
314.00 (F90.0) Predominantly inattentive presentation
314.01 (F90.1) Predominantly hyperactive/impulsive presentation

Specify if: In partial remission
Specify current severity: Mild, Moderate, Severe

314.01 (F90.8) Other Specified Attention-Deficit/Hyperactivity Disorder (65)

314.01 (F90.9) Unspecified Attention-Deficit/Hyperactivity Disorder (66)

Specific Learning Disorder (66)
___.__ (___.__) Specific Learning Disorder (66)

Specify if:
315.00 (F81.0) With impairment in reading {specify if with word reading

accuracy, reading rate or fluency, reading comprehension)
315.2 (F81.81 ) With impairment in written expression {specify if with spelling

accuracy, grammar and punctuation accuracy, clarity or
organization of written expression)

315.1 (F81.2) With impairment in mathematics {specify if with number sense,
memorization of arithmetic facts, accurate or fluent
calculation, accurate math reasoning)

Specify current severity: Mild, Moderate, Severe

Motor Disorders (74)
315.4 (F82) Developmental Coordination Disorder (74)

307.3 (F98.4) Stereotypic Movement Disorder (77)
Specify if: With self-injurious behavior. Without self-injurious behavior
Specify if: Associated with a known medical or genetic condition, neuro­

developmental disorder, or environmental factor
Specify current severity: Mild, Moderate, Severe

Tic Disorders
307.23 (F95.2) Tourette’s Disorder (81)

307.22 (F95.1) Persistent (Chronic) Motor or Vocal Tic Disorder (81)
Specify if: With motor tics only. With vocal tics only

307.21 (F95.0) Provisional Tic Disorder (81)

307.20 (F95.8), Other Specified Tic Disorder (85)

307.20 (F95.9) Urispecified Tic Disorder (85)

Other Neurodevelopmental Disorders (86)
315.8 (FSB) Other Specified Neurodevelopmental Disorder (86)

315.9 (F89) Unspecified Neurodevelopmental Disorder (86)

Schizophrenia Spectrum
and Other Psychotic Disorders (87)

The following specifiers apply to Schizophrenia Spectrum and Other Psychotic Disorders
where indicated:
^Specify if: The following course specifiers are only to be used after a 1-year duration of the dis­

order: First episode, currently in acute episode; First episode, currently in partial remission;
First episode, currently in full remission; Multiple episodes, currently in acute episode; Mul­
tiple episodes, currently in partial remission; Multiple episodes, currently in full remission;
Continuous; Unspecified

^Specify if: With catatonia (use additional code 293.89 [F06.1])
^Specify current severity of delusions, hallucinations, disorganized speech, abnormal psycho­

motor behavior, negative symptoms, impaired cognition, depression, and mania symptoms

301.22 (F21)

297.1 (F22)

298.8 (F23)

295.40 (F20.81)

295.90 (F20.9)

295.70 (F25.0)
295.70 (F25.1)

293.81 (F06.2)
293.82 (F06.0)

Schizotypal (Personality) Disorder (90)

Delusional Disorder^’ ̂ (90)
Specify whether: Erotomanie type. Grandiose type. Jealous type. Persecu­

tory type. Somatic type. Mixed type. Unspecified type
Specify if: With bizarre content
Brief Psychotic Disorder^’ ̂ (94)
Specify if: With marked stressor(s). Without marked stressor(s). With

postpartum onset
Schizophreniform Disorder^’ ̂ (96)
Specify if: With good prognostic features. Without good prognostic fea­

tures
Schizophrenia^’ ̂ (99)

Schizoaffective Disorder^’ ̂ (105)
Specify whether:

Bipolar type
Depressive type

Substance/Medication-Induced Psychotic Disorder^ (110)
Note: See the criteria set and corresponding recording procedures for

substance-specific codes and ICD-9-CM and ICD-IO-CM coding.
Specify if: With onset during intoxication. With onset during withdrawal

Psychotic Disorder Due to Another Medical Condition^ (115)
Specify whether:

With delusions
With hallucinations

293.89 (F06.1) Catatonia Associated With Another Mental Disorder (Catatonia
Specifier) (119)

293.89 (F06.1) Catatonic Disorder Due to Another Medical Condition (120)

293.89 (F06.1) Unspecified Catatonia (121)
Note: Code first 781.99 (R29.818) other symptoms involving nervous and

musculoskeletal systems.
298.8 (F28) Other Specified Schizophrenia Spectrum and Other Psychotic

Disorder (122)

298.9 (F29) Unspecified Schizophrenia Spectrum and Other Psychotic
Disorder (122)

Bipolar and Related Disorders (123)
The following specifiers apply to Bipolar and Related Disorders where indicated:

Ŝpecify: With anxious distress (specify current severity: mild, moderate, moderate-severe, severe);
With mixed features; With rapid cycling; With melancholic features; With atypical features;
With mood-congruent psychotic features; With mood-incongruent psychotic features; With
catatonia (use additional code 293.89 [F06.1]); With péripartum onset; With seasonal pattem

296.41
296.42
296.43
296.44
296.45
296.46
296.40
296.40
296.45
296.46
296.40

296.51
296.52
296.53
296.54
296.55
296.56
296.50
296.7

(F31.11)
(F31.12)
(F31.13)
(F31.2)
(F31.73)
(F31.74)
(F31.9)
(F31.0)
(F31.73)
(F31.74)
(F31.9)

(F31.31)
(F31.32)
(F31.4)
(F31.5)
(F31.75)
(F31.76)
(F31.9)
(F31.9)

296.89 (F31.81)

Bipolar I Disorder® (123)
Current or most recent episode manic

Mild
Moderate
Severe
With psychotic features
In partial remission
In full remission
Unspecified

Current or most recent episode hypomanie
In partial remission
In kill remission
Unspecified

Current or most recent episode depressed
Mild
Moderate
Severe
With psychotic features
In partial remission
In full remission
Unspecified

Current or most recent episode unspecified

Bipolar II Disorder® (132)
Specify current or most recent episode: Hypomanie, Depressed
Specify course if full criteria for a mood episode are not currently met: In

partial remission. In full remission
Specify severity if full criteria for a mood episode are not currently met:

Mild, Moderate, Severe

301.13 (F34.0)
y

293.83 (__ ._ )

(F06.33)
(F06.33)
(F06.34)

296.89 (F31.89)

296.80 (F31.9)

Cyclothymic Disorder (139)
Specify if: With anxious distress

Substance/Medication-Induced Bipolar and Related Disorder (142)
Note: See the criteria set and corresponding recording procedures for

substance-specific codes and ICD-9-CM and ICD-IO-CM coding.
Specify if: With onset during intoxication. With onset during withdrawal

Bipolar and Related Disorder Due to Another Medical Condition
(145)

Specify if:
With manic features
With manic- or hypomanic-like episode
With mixed features

Other Specified Bipolar and Related Disorder (148)

Unspecified Bipolar and Related Disorder (149)

Depressive Disorders (155)
The following specifiers apply to Depressive Disorders where indicated:
^Specify: With anxious distress (specify current severity: mild, moderate, moderate-severe,

severe); With mixed features; With melancholic features; With atypical features; With mood-
congruent psychotic features; With mood-incongruent psychotic features; With catatonia
(use additional code 293.89 [F06.1]); With péripartum onset; With seasonal pattern

296.99 (F34.8) Disruptive Mood Dysregulation Disorder (156)

. ( _ ■ ) Major Depressive Disorder® (160)

. ( _ . ) Single episode
296.21 (F32.0) Mild
296.22 (F32.1) Moderate
296.23 (F32.2) Severe
296.24 (F32.3) With psychotic features
296.25 (F32.4) In partial remission
296.26 (F32.5) In full remission
296.20 (F32.9) Unspecified

. ( _ · ) Recurrent episode
296.31 (F33.0) Mild
296.32 (F33.1) Moderate
296.33 (F33.2) Severe
296.34 (F33.3) With psychotic features
296.35 (F33.41) In partial remission
296.36 (F33.42) In full remission
296.30 (F33.9) Unspecified
300.4 (F34.1) Persistent Depressive Disorder (Dysthymia)® (168)

Specify if: In partial remission. In full remission
Specify if: Early onset. Late onset
Specify if: With pure dysthymic syndrome; With persistent major depres­

sive episode; With intermittent major depressive episodes, with current

625.4 (N94.3)

(_ _ ■ _ )

293.83 (__ ._ )

(F06.31)
(F06.32)
(F06.34)

311 (F32.8)

311 (F32.9)

episode; With intermittent major depressive episodes, without current
episode

Specify current severity: Mild, Moderate, Severe
Premenstrual Dysphoric Disorder (171)

Substance/Medication-Induced Depressive Disorder (175)
No

Place your order now for a similar assignment and have exceptional work written by one of our experts, guaranteeing you an A result.

Need an Essay Written?

This sample is available to anyone. If you want a unique paper order it from one of our professional writers.

Get help with your academic paper right away

Quality & Timely Delivery

Free Editing & Plagiarism Check

Security, Privacy & Confidentiality